Current with legislation from the 2023 Regular and Special Sessions signed by the Governor as of November 21, 2023.
Section 531.069 - [Repealed Effective 4/1/2025] Periodic Review of Vendor Drug Program(a) The commission shall periodically review all purchases made under the vendor drug program to determine the cost-effectiveness of including a component for prescription drug benefits in any capitation rate paid by the state under a Medicaid managed care program or the child health plan program.(b) In making the determination required by Subsection (a), the commission shall consider the value of any prescription drug rebates received by the state.Tex. Gov't. Code § 531.069
Repealed by Acts 2023, Texas Acts of the 88th Leg.- Regular Session, ch. 769,Sec. 3.01, eff. 4/1/2025.Added by Acts 2003, 78th Leg., ch. 198, Sec. 2.10, eff. 9/1/2003.